Cargando…
Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C
BACKGROUND/AIMS: The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon α-2b plus ribavirin therapy in patients with high viral load genotype 1b hepatitis C. METHODS: The participants consisted of 72...
Autores principales: | Wada, Yuki, Tamai, Hideyuki, Kawashima, Akira, Shingaki, Naoki, Mori, Yoshiyuki, Kawaguchi, Masanori, Moribata, Kosaku, Deguchi, Hisanobu, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113039/ https://www.ncbi.nlm.nih.gov/pubmed/25071908 http://dx.doi.org/10.5009/gnl.2014.8.4.421 |
Ejemplares similares
-
Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
por: Tamai, Hideyuki, et al.
Publicado: (2016) -
Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus
por: Tamai, Hideyuki, et al.
Publicado: (2017) -
Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography
por: Nakachi, Kenichiro, et al.
Publicado: (2014) -
Video capsule endoscopy as the initial examination for overt obscure gastrointestinal bleeding can efficiently identify patients who require double-balloon enteroscopy
por: Maeda, Yoshimasa, et al.
Publicado: (2015) -
Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
por: Sanda, Mariko, et al.
Publicado: (2011)